Budget Impact Analysis Of Subcutaneous Belimumab In Patients With Systemic Lupus Erythematosus In Spain

Budget Impact Analysis Of Subcutaneous Belimumab In Patients With Systemic Lupus Erythematosus In Spain

Maria Cevey,1 Jaime Calvo-Alén,2 Carlos Crespo,3 Angel Robles-Marhuenda,4 Lee Smolen,5 Josefina Cortés-Hernández6 1Department of Market Access, GlaxoSmithKline SA, Madrid, Spain; 2Department of Rheumatology, University Hospital Araba, Vitoria, Spain; 3Department of G...

Full description

Bibliographic Details
Main Authors: Cevey M, Calvo-Alén J, Crespo C, Robles-Marhuenda A, Smolen L, Cortés-Hernández J
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
belimumab
budget impact
spanish national health service (nhs)
systemic lupus erythematosus
Online Access:https://www.dovepress.com/budget-impact-analysis-of-subcutaneous-belimumab-in-patients-with-syst-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/budget-impact-analysis-of-subcutaneous-belimumab-in-patients-with-syst-peer-reviewed-article-CEOR

Similar Items